XLO
Xilio Therapeutics, Inc. Common StockstockNASDAQ
xilio is a waltham, massachusetts-based biopharmaceutical company focused on defeating cancer. the company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, xilio, derived from the latin term, ex nihilo, meaning creation or big-bang. xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. to learn more, please visit www.xiliotx.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.47 | 2026-11-11 | -11.22% | 1.389 |
| 1M | 8.33 | 2026-10-19 | -9.72% | 1.084 |
| 3M | 9.50 | 2026-08-18 | -20.84% | 1.011 |
| 6M | 8.15 | 2026-05-18 | -7.73% | 0.868 |
| 1Y | 10.50 | 2025-11-18 | -28.38% | 0.862 |
| 2Y | 13.61 | 2024-11-18 | -44.76% | — |
| 5Y | 340.06 | 2021-11-18 | -97.79% | 0.886 |
Xilio Therapeutics, Inc. Common Stock (NASDAQ:XLO) stock price today is $7.52, and today's volume is 8,548. XLO is down 0.265% today. The 30 day average volume is 13,783. XLO market cap is $53.12M with 7.06M shares outstanding.